Roquette, a company involved in plant-based ingredients and a provider of pharmaceutical and nutraceutical excipients, added three new excipient grades to its portfolio of solutions for moisture sensitive active pharmaceutical and nutraceutical ingredients. Unveiled at CPHI Barcelona, LYCATAB CT-LM partially pregelatinized starch, MICROCEL 103 SD and MICROCEL 113 SD microcrystalline cellulose offer a unique range of stabilizing and moisture protective benefits, giving pharmaceutical manufacturers the tools, they need to optimize any drug delivery, regardless of production method or formulation type.
LA MADELEINE, France & THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Roquette, a leading provider of pharmaceutical excipients and global leader in plant-based ingredients, is pleased to announce a strategic investment with Beren Therapeutics P.B.C., and the launch of an innovation agreement to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
La Madeleine, France, and Philadelphia, USA – April 19, 2023. Roquette, a global leader in plant-based ingredients and a leading provider of pharmaceutical and nutraceutical excipients, today celebrates the grand opening of its new Pharmaceutical Innovation Center, located near Philadelphia, Pennsylvania, right in the heart of the United States’ Northeastern pharmaceutical corridor. Staffed with a team of highly skilled research, application and formulation experts, the new $25 million center will be an advanced training and collaboration hub for pharmaceutical and nutraceutical manufacturers around the world. With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore.
Roquette, a company involved in plant-based ingredients and a leading provider of pharmaceutical and nutraceutical excipients, opened its new pharmaceutical innovation center near Philadelphia.
Roquette, a leader in plant-based ingredients and a leading provider of pharmaceutical and nutraceutical excipients, has launched two next-generation mannitol products for direct compression – Pearlitol CR-H and Pearlitol 200 GT.
Pennsylvania, the new state-of-the-art facility aims to better serve nRoquette’s global customer base by working closely with its specialist npharmaceutical teams, based at sister sites in Singapore and France, to nadvance the research of Drug Delivery systems for oral prescription drugs and Nutraceutical APIs.nnnnnnnRoquette,na provider of plant-based ingredients and naturally-derived npharmaceutical excipients, is investing $25 million in a new Innovation nCenter in the U.S. to expand its pharmaceutical business. Located in nPennsylvania, the new state-of-the-art facility aims to better serve nRoquette’s global customer base by working closely with its specialist npharmaceutical teams, based at sister sites in Singapore and France, to nadvance the research of Drug Delivery systems for oral prescription drugs and Nutraceutical APIs.
Roquette has completed its takeover of Brazil-based drug excipient firm Itacel.
Ingredients manufacturer Roquette says it will acquire Blancer’s Brazil-based excipient division, Itacel, to meet market demand.
Roquette, a global leader in innovative plant-based ingredients, announced its first acquisition in the pharmaceutical excipients market. The acquisition of Itacel will reinforce Roquette’s position as a major supplier to the pharmaceutical industry and a global leader in natural-based pharmaceutical excipients solutions. The combination of the two businesses will contribute to Roquette’s strategic growth plan in the Food, Nutrition and Health markets, and will create new opportunities for Roquette and Blanver’s customers and employees.
New product offerings are low endotoxin, multi-compendial-grade materials for cell culture and biologic drug formulations. These products extend Roquette's commitment to helping customers save and sustain patients’ lives.